Can Hydrogen Therapy Reduce IMRT-Induced Bone Marrow Damage?
Clinical observations and new hope for recovery from the perspective of cancer patients
Free cancer support
For many cancer patients, the battle is not only against the tumor itself, but also against the physical toll of treatment. Even though intensity-modulated radiation therapy (IMRT) is more precise than traditional radiotherapy, its side effects—especially bone marrow suppression—remain a major challenge that affects patients’ safety, immunity, and overall quality of life.
Low white blood cell counts, low platelets, fatigue, dizziness, increased risk of infection, and spontaneous bruising are all common experiences. Patients endure these symptoms silently, often wondering:
“Does cancer treatment really have to be this hard? Is there a safer way to protect my body during therapy?”
A new observational study conducted at the C4 Clinic in Tokyo, Japan, offers an encouraging perspective. The research found that hydrogen therapy may help reduce bone marrow damage caused by IMRT—without weakening its anti-tumor effects. This finding brings new hope to patients who long for a treatment journey that is effective yet less physically burdensome.
IMRT Is More Precise, But Bone Marrow Suppression Still Happens
IMRT has become a standard treatment for many cancers because it allows radiation to directly target the tumor while protecting nearby normal tissues. However, bone marrow is a sensitive organ responsible for producing blood cells. When a portion of the bone marrow is exposed to radiation—even with IMRT’s precision—it can still be damaged.
As a result, many patients experience:
- Low white blood cells → increased risk of infection
- Low platelets → easy bruising, gum bleeding
- Declining red blood cells → fatigue, shortness of breath
- Fear of treatment interruption due to low counts
These problems can be emotionally overwhelming. Instead of worrying only about the cancer, patients often find themselves worrying about whether their body can survive the treatment.
This is precisely why scientists have begun searching for methods to protect bone marrow during IMRT.
Recent scientific discoveries show that hydrogen is not merely a simple gas—it has powerful biological effects:
- It acts as a selective antioxidant
- It neutralizes highly toxic free radicals such as hydroxyl radicals and peroxynitrite
- It reduces inflammation
- It protects cells and tissues from oxidative stress
Since radiotherapy produces a large amount of free radicals that damage blood-forming cells, hydrogen therapy could theoretically reduce this damage. This possibility led researchers to question:
Can hydrogen therapy protect bone marrow during IMRT?
Why Hydrogen Therapy?
Study Design: Real Patients, Real Treatment Conditions
This observational study took place at the C4 Clinic in Tokyo between May 2015 and November 2016. All participants received IMRT once daily for a treatment duration of 1 to 4 weeks.
The patients were divided into two groups:
Control Group (n = 7)
- 3 males, 4 females
- Ages 26–70
- Received 30 minutes of mild hyperbaric oxygen therapy after each IMRT session
Hydrogen Therapy Group (n = 16)
- 8 males, 8 females
- Ages 35–82
- Received 30 minutes of 5% hydrogen gas inhalation after each IMRT session
To evaluate bone marrow function, blood samples were collected before and after IMRT to measure:
- White blood cells
- Platelets
- Red blood cells
- Hemoglobin
- Hematocrit
Both groups received similar radiation doses and number of sessions, ensuring reliable comparison.
Study Findings: Hydrogen Therapy Significantly Reduced Bone Marrow Damage
IMRT + Hyperbaric Oxygen Group
After IMRT, the control group showed:
- Significant drops in white blood cell counts
- Significant drops in platelets
- No improvement in red blood cells, hemoglobin, or hematocrit
These results mirror what many cancer patients commonly experience during radiation therapy.
Hydrogen Therapy Group: A Very Different Pattern Emerged
Hydrogen therapy significantly protected bone marrow function:
1. It reduced the drop in white blood cells (P = 0.0011)
This means lower infection risk and more stable immune function.
2. It reduced the decline in platelets (P = 0.0275)
This reduces the risk of bleeding and improves everyday safety.
3. Both groups had similar tumor responses
This is crucial:
Hydrogen therapy did NOT weaken IMRT’s ability to kill cancer cells.
To patients, this is profoundly reassuring. Many worry that supportive therapies may interfere with cancer treatment. This study shows that hydrogen therapy offers protection without compromising IMRT’s benefits.
Safety: Hydrogen Therapy Did Not Cause Any Side Effects
Throughout the study, patients tolerated hydrogen therapy well.
There were no treatment-related adverse reactions.
For patients already dealing with:
- fatigue
- nausea
- weakness
- lowered immunity
it is especially important to have a protective therapy that does not add further strain to the body.
What This Means for Cancer Patients
1. Less suffering during treatment
Bone marrow suppression is one of the most feared complications during IMRT. Hydrogen therapy could reduce this burden, helping patients feel safer and less anxious throughout their treatment journey.
2. Better chance of completing treatment without delays
Many patients experience treatment interruptions due to dangerously low blood counts. By protecting bone marrow, hydrogen therapy may help patients maintain stable levels and complete treatment on schedule.
3. It does not interfere with tumor control
This is the most important reassurance for patients:
Hydrogen therapy protects the body but does not protect the tumor.
This balance is rare and extremely valuable in oncology care.
Patient Voices: “What I Need Is Not More Strength—It’s Less Damage.”
Patients undergoing IMRT often share similar feelings:
- “The hardest part isn’t the cancer—it’s how weak treatment makes me feel.”
- “If something could help my white blood cell count stay up, I’d feel much safer.”
- “I don’t want to pause treatment. I want something to help my body keep up.”
- “If I could stay stronger during therapy, I’d feel more hopeful.”
Hydrogen therapy gives patients exactly that—
a chance to undergo treatment without feeling like their body is falling apart.
Conclusion: Hydrogen Therapy Is Not a Miracle, but It Is a Promising Supportive Option
This study demonstrated:
- Hydrogen therapy reduces IMRT-induced bone marrow damage
- It stabilizes white blood cells and platelets
- It does not reduce IMRT’s anti-tumor effect
- It is safe, gentle, and well tolerated
For cancer patients, treatment should not only be effective—it should also be humane. Hydrogen therapy represents a new approach that protects the body while allowing treatment to continue without interruption.
As more clinical studies emerge, hydrogen therapy may become an important supportive strategy in cancer care, helping patients navigate IMRT with greater confidence, safety, and strength.
Want to know how to choose the most suitable adjuvant therapy for cancer?
Contact our professional team now
References
- Kawamura, T., Wakabayashi, N., Shigemura, N., Yamada, M., Saito, T., Yoshino, Y., … & Onishi, H. (2021). Hydrogen gas treatment mitigates bone marrow damage induced by intensity-modulated radiation therapy in cancer patients: An observational study. Medical Gas Research, 11(2), 88-94. https://pubmed.ncbi.nlm.nih.gov/33942780/